SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma
Liver Hepatocellular Carcinoma (LIHC) is the fifth widely occurred carcinoma, which is thought to be the second primary contributor of carcinoma-associated death. There are almost 788,000 death tolls worldwide. Solute carrier family 41 member 3 (SLC41A3) is a member of solute carrier family 41, and...
Guardado en:
Autores principales: | Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a7818cd49c449fab1d2d834420a1ea2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation
por: Qi Zhang, et al.
Publicado: (2021) -
Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases
por: Shan Gao, et al.
Publicado: (2021) -
Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma
por: Youfang Liang, et al.
Publicado: (2021) -
Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines
por: Mingxuan Xing, et al.
Publicado: (2021) -
Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma
por: Xiaolong Tang, et al.
Publicado: (2021)